NOVELTY: a landmark study in phenotyping and endotyping chronic obstructive airway diseases in real clinical practice

Renaud Louis, Gilles Louis, Olivier Bonhomme

Source: Eur Respir J, 58 (3) 2100627; 10.1183/13993003.00627-2021
Journal Issue: September
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Renaud Louis, Gilles Louis, Olivier Bonhomme. NOVELTY: a landmark study in phenotyping and endotyping chronic obstructive airway diseases in real clinical practice. Eur Respir J, 58 (3) 2100627; 10.1183/13993003.00627-2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The future of disease monitoring and management: the homework for clinical researchers
Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not?
Year: 2005

Underrepresentation of patients with cardiovascular diseases in trials of chronic obstructive pulmonary disease: Transferability problems in general practice?
Source: Annual Congress 2010 - Management of airway disease
Year: 2010

The role of cluster analysis in defining phenotypes of obstructive airway diseases: is there a need for a new taxonomy of obstructive airway diseases?
Source: Annual Congress 2011 - PG11 Update of phenotypes of asthma and COPD
Year: 2011



Epidemiological aspects and early detection of chronic obstructive airway diseases in the elderly
Source: Eur Respir J 2003; 21: 3S-9S
Year: 2003



Biomarkers of airways inflammation in patients with severe asthma in a real clinical practice
Source: International Congress 2019 – Long-term evaluation and control of airway diseases
Year: 2019


Azithromycin to prevent exacerbations of chronic obstructive pulmonary disease: a study in the real-world setting
Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD
Year: 2020


Need for generalized criteria in evaluating the impact of new drugs in clinical trials involving patients suffering from COPD
Source: Annual Congress 2006 - Outcomes for COPD pharmacological trials: from lung function to biomarkers
Year: 2006


Can roflumilast improve clinical outcomes in moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016

Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice
Source: Eur Respir J 2013; 41: 1252-1256
Year: 2013



The role of inflammatory biomarkers and health related quality of life questionnaires in distinction of exacerbation and stable chronic obstructive pulmonary diseases
Source: International Congress 2014 – Markers
Year: 2014


The clinical characteristics of eosinophilic chronic obstructive pulmonary disease:A cohort study
Source: Virtual Congress 2020 – Investigations of COPD
Year: 2020

Clinical and inflammatory phenotyping by breathomics in chronic airway diseases irrespective of the diagnostic label
Source: Eur Respir J, 51 (1) 1701817; 10.1183/13993003.01817-2017
Year: 2018



Patients and families realizing their future with chronic obstructive pulmonary disease - a qualitative study
Source: International Congress 2017 – Nursing practice across respiratory care pathways
Year: 2017

Measuring inflammation inpaediatric severe asthma: biomarkers in clinical practice
Source: Breathe, 16 (1) 889; 10.1183/20734735.0301-2019
Year: 2020



How to increase the value of randomised trials in COPD research
Source: Eur Respir J 2009; 34: 552
Year: 2009



How to screen chronic obstructive pulmonary disease in general practice?
Source: International Congress 2015 – Respiratory disease management in primary care
Year: 2015


Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: 243-244
Year: 2002


Differentiating asthma from chronic obstructive pulmonary disease (COPD) in medico-economic databases: myth or reality?
Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry
Year: 2019


Clinical and economical impact of exacerbations of chronic obstructive pulmonary disease (COPD): A two-year study
Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Year: 2011

Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study
Source: Eur Respir J 2009; 34: 588
Year: 2009